IMRX vs. NGD

Last updated Jun 13, 2026

IMRX (Immuneering Corporation) and NGD (New Gold Inc.) are both stocks. IMRX operates in Biotechnology (Healthcare), while NGD operates in Gold (Basic Materials). At a 0.08 correlation, their price movements are largely independent.

Performance

IMRX vs. NGD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Immuneering Corporation (IMRX) and New Gold Inc. (NGD). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

IMRX

• 1D: 1.70%
• 1M: -22.12%
• YTD: -36.32%
• 6M: -31.09%
• 1Y: 113.78%
• 3Y*: -24.01%
• 5Y*: —
• 10Y*: —

NGD

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

IMRX vs. NGD - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
IMRX Immuneering Corporation	-36.32%	199.09%	-70.07%	51.55%	-70.01%	-17.08%
NGD New Gold Inc.	4.25%	251.21%	69.86%	48.98%	-34.67%	-10.18%

Correlation

The correlation between IMRX and NGD is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.04
Correlation (3Y) Calculated over the trailing 3-year period	0.11
Correlation (All Time) Calculated using the full available price history since Jul 30, 2021	0.08

Fundamentals

EPS IMRX : -$293.00 NGD : $1.61
Total Revenue (TTM) IMRX : $0.00 NGD : $1.46B
Gross Profit (TTM) IMRX : -$698.89K NGD : $758.26M
EBITDA (TTM) IMRX : -$15.38B NGD : $1.19B

Return for Risk

IMRX vs. NGD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IMRX

IMRX Risk / Return Rank: 75
IMRX Sharpe Ratio Rank: 72
IMRX Sortino Ratio Rank: 78
IMRX Omega Ratio Rank: 81
IMRX Calmar Ratio Rank: 76
IMRX Martin Ratio Rank: 70

NGD

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IMRX vs. NGD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Immuneering Corporation (IMRX) and New Gold Inc. (NGD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	IMRX	NGD	Difference
Sharpe ratio: Return per unit of total volatility	0.92	—	—
Sortino ratio: Return per unit of downside risk	2.05	—	—
Omega ratio: Gain probability vs. loss probability	1.29	—	—
Calmar ratio: Return relative to maximum drawdown	1.98	—	—
Martin ratio: Return relative to average drawdown	3.30	—	—

Drawdowns

Drawdown Indicators

	IMRX	NGD	Difference
Max Drawdown Largest peak-to-trough decline	-96.86%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-57.67%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-90.98%	—	—
Current Drawdown Current decline from peak	-87.24%	—	—
Average Drawdown Average peak-to-trough decline	-77.61%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	34.56%	—	—

Volatility

Volatility by Period

	IMRX	NGD	Difference
Volatility (1M) Calculated over the trailing 1-month period	33.75%	—	—
Volatility (6M) Calculated over the trailing 6-month period	79.00%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	124.22%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	114.45%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	114.45%	—	—

Dividends

IMRX vs. NGD - Dividend Comparison

Neither IMRX nor NGD has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both IMRX and NGD in my portfolio?

IMRX and NGD have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.